KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Steris (STE) EBITDA (2018 - 2025)

Historic EBITDA for Steris (STE) over the last 8 years, with Q4 2025 value amounting to $273.2 million.

  • Steris' EBITDA rose 1137.38% to $273.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 1496.35%. This contributed to the annual value of $866.6 million for FY2025, which is 365.06% up from last year.
  • Steris' EBITDA amounted to $273.2 million in Q4 2025, which was up 1137.38% from $265.8 million recorded in Q3 2025.
  • Steris' EBITDA's 5-year high stood at $748.3 million during Q1 2023, with a 5-year trough of -$306.4 million in Q3 2022.
  • Its 5-year average for EBITDA is $195.0 million, with a median of $200.3 million in 2021.
  • Over the last 5 years, Steris' EBITDA had its largest YoY gain of 100580.15% in 2022, and its largest YoY loss of 36301.04% in 2022.
  • Steris' EBITDA (Quarter) stood at $202.9 million in 2021, then decreased by 5.98% to $190.8 million in 2022, then rose by 18.69% to $226.5 million in 2023, then rose by 8.31% to $245.3 million in 2024, then rose by 11.37% to $273.2 million in 2025.
  • Its EBITDA was $273.2 million in Q4 2025, compared to $265.8 million in Q3 2025 and $246.0 million in Q2 2025.